K.CaseyC
Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market
N Engl J Med (1993) 329:97786
Many oral options are compounded, so absorption and potency can vary
Van Herreweghe F, Mao J, Chaplen FW, Grooten J, Gevaert K, Vandekerckhove J, et al
Trimi's published homepage displays a figure of 53,585+ patients, which should be treated as brand-stated information - it hasn't been independently audited by this publication